(Q36462680)

14 August 2017

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease (English)

1 reference

14 August 2017

1 reference

Isabelle St-Amour

1

0 references

Frédéric Calon

7

1 reference

14 August 2017

author name string

Mélanie Bousquet

2

1 reference

14 August 2017

Isabelle Paré

3

1 reference

14 August 2017

Janelle Drouin-Ouellet

4

1 reference

14 August 2017

Francesca Cicchetti

5

1 reference

14 August 2017

Renée Bazin

6

1 reference

14 August 2017

9 October 2012

1 reference

Journal of Neuroinflammation

14 August 2017

1 reference

14 August 2017

9

1 reference

14 August 2017

234

1 reference

describes a project that uses

14 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3520736/fullTextXML

inferred from PubMed Central ID database lookup

exact match

https://scigraph.springernature.com/pub.10.1186/1742-2094-9-234

0 references

cites work

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Classic and new animal models of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Pathological roles of α-synuclein in neurological disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

A tale on animal models of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Tyrosine hydroxylase and regulation of dopamine synthesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Control of Th2-mediated inflammation by regulatory T cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

FOXP3+ regulatory T cells in the human immune system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Missing pieces in the Parkinson's disease puzzle

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Involvement of Fc receptors in disorders of the central nervous system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Role of natural antibodies in immune homeostasis: IVIg perspective.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Anti-inflammatory actions of intravenous immunoglobulin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Protocol for the MPTP mouse model of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Behavioral models of Parkinson's disease in rodents: a new look at an old problem

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Clinical pharmacology and neuroprotection in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Modulation of tyrosine hydroxylase, neuropeptide y, glutamate, and substance p in Ganglia and brain areas involved in cardiovascular control after chronic exposure to nicotine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Apoptosis of peripheral blood lymphocytes in Parkinson patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson's disease.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Interleukin-6 serum levels in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

CD4+/CD8+ macrophages infiltrating at inflammatory sites: a population of monocytes/macrophages with a cytotoxic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

IVIg attenuates T cell-mediated killing of human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Progesterone receptor isoforms differentially regulate the expression of tryptophan and tyrosine hydroxylase and glutamic acid decarboxylase in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520736

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

21 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases: A Mechanistic Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1742-2094-9-234

Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease

21 January 2018

1 reference

12 December 2020

IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment

1 reference

12 December 2020

Intravenous immunoglobulin G (IVIG) inhibits IL-1- and TNF-α-dependent, but not chemotactic-factor-stimulated, neutrophil transendothelial migration

1 reference

12 December 2020

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

12 December 2020

Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease

1 reference

12 December 2020

Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo

1 reference

12 December 2020

Parkinson’s disease is associated with increased serum levels of macrophage migration inhibitory factor

1 reference

12 December 2020

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice

1 reference

12 December 2020

Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin

1 reference

12 December 2020

1 reference

12 December 2020

Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy

1 reference

12 December 2020

High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis

1 reference

12 December 2020

Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors

1 reference

12 December 2020

Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression

1 reference

12 December 2020

A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism

1 reference

12 December 2020

Identifiers

DOI

10.1186/1742-2094-9-234

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference